A systematic review of evaluations of prison-based alcohol and other drug use behavioural treatment for men.


Journal

Australian and New Zealand journal of public health
ISSN: 1753-6405
Titre abrégé: Aust N Z J Public Health
Pays: United States
ID NLM: 9611095

Informations de publication

Date de publication:
Apr 2019
Historique:
received: 01 09 2018
revised: 01 06 2018
accepted: 01 01 2019
pubmed: 26 3 2019
medline: 9 5 2019
entrez: 26 3 2019
Statut: ppublish

Résumé

A history of alcohol and other drug (AoD) use is common among men entering prison and often linked to the crime for which they are imprisoned. This is the first systematic review of prison-based, behavioural AoD treatment programs for more than a decade and the first that reviews the methodological quality of evaluations. This review aims to create an understanding of the quality of research in this field and identify the most effective AoD use treatment for men in prison. A PRISMA-compliant systematic review of international, peer-reviewed research published between January 1995 and December 2015. The Dictionary for Effective Public Health Practice Project was used to assess the methodological quality of papers. A total of 25 relevant papers were identified, of which 12 were rated as methodologically sound. Four of these measured post-release AoD use and three reported statistically significant reductions in AoD use. Although there is relatively little methodologically strong evidence of the impact of prison-based AoD treatment, and no Australian papers studies, current best-evidence practice is Cognitive behavioural therapy delivered in Therapeutic Community (TC) settings. Implications for public health: Prison-based TC treatment should be available to people in prison who have a history of AoD use.

Identifiants

pubmed: 30908856
doi: 10.1111/1753-6405.12884
doi:

Types de publication

Journal Article Systematic Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

120-130

Informations de copyright

© 2019 The Authors.

Auteurs

Michael F Doyle (MF)

Sydney Medical School, The University of Sydney, New South Wales.

Anthony Shakeshaft (A)

National Drug and Alcohol Research Centre, University of New South Wales.

Jill Guthrie (J)

National Centre for Epidemiology and Population Health, The Australian National University, Australian Capital Territory.

Mieke Snijder (M)

National Drug and Alcohol Research Centre, University of New South Wales.

Tony Butler (T)

Kirby Institute, University of New South Wales.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH